These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 9692646)

  • 1. Budesonide inhalation powder: a review of its pharmacologic properties and role in the treatment of asthma.
    Davis KC; Small RE
    Pharmacotherapy; 1998; 18(4):720-8. PubMed ID: 9692646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Budesonide (Turbuhaler) at a dosage of 400 micrograms per day is at least as effective as a double dose of beclomethasone (MDI) in patients with mild to moderately severe bronchial asthma].
    Vondra V; Kraszkó P; Malolepszy J
    Cas Lek Cesk; 1999 Jan; 138(3):78-81. PubMed ID: 10376390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K; Noonan M; Silkoff PE; Uryniak T
    Clin Ther; 2007 Jun; 29(6):1013-26. PubMed ID: 17692718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of inhaled corticosteroids in asthma.
    Jackson LD; Polygenis D; McIvor RA; Worthington I
    Can J Clin Pharmacol; 1999; 6(1):26-37. PubMed ID: 10465863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.
    Piquet J; Zuck P; Dennewald G; Dugue P; Grivaux M; Brun P; Severac JC; Ostinelli J; Cheeseman KH
    Adv Ther; 1996; 13(1):38-50. PubMed ID: 10172710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of budesonide in moderate to severe asthma.
    O'Connell EJ
    Clin Ther; 2002 Jun; 24(6):887-905; discussion 837. PubMed ID: 12117080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler.
    Selroos O; Halme M
    Thorax; 1991 Dec; 46(12):891-4. PubMed ID: 1792636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparable effects of inhaled fluticasone propionate and budesonide on the HPA-axis in adult asthmatic patients.
    Ringdal N; Lundbäck B; Alton M; Rak S; Eivindson A; Bratten G; Kjaersgaard P
    Respir Med; 2000 May; 94(5):482-9. PubMed ID: 10868712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluticasone propionate plasma concentration and systemic effect: effect of delivery device and duration of administration.
    Whelan GJ; Blumer JL; Martin RJ; Szefler SJ;
    J Allergy Clin Immunol; 2005 Sep; 116(3):525-30. PubMed ID: 16159619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing inhaled corticosteroid therapy in children with chronic asthma.
    O'Connell EJ
    Pediatr Pulmonol; 2005 Jan; 39(1):74-83. PubMed ID: 15532098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():5-10. PubMed ID: 15688663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new trend of inhaled corticosteroid therapy in Japan].
    Sano Y
    Nihon Rinsho; 1996 Nov; 54(11):3004-10. PubMed ID: 8950945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U; Price D; Howes T; Sussman G
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma.
    Tinkelman DG; Bronsky EA; Gross G; Schoenwetter WF; Spector SL
    J Asthma; 2003 May; 40(3):225-36. PubMed ID: 12807165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler.
    Toogood JH; White FA; Baskerville JC; Fraher LJ; Jennings B
    J Allergy Clin Immunol; 1997 Feb; 99(2):186-93. PubMed ID: 9042043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.
    Selroos O; Edsbäcker S; Hultquist C
    J Asthma; 2004; 41(8):771-90. PubMed ID: 15641626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) is effective and safe in adults previously treated with inhaled corticosteroids.
    Metzger WJ; Hampel FC; Sugar M
    J Asthma; 2002 Feb; 39(1):65-75. PubMed ID: 11883741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of treatment with budesonide (Pulmicort) in corticosteroid-dependent intrinsic asthma].
    Petri E
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1782-4. PubMed ID: 4089578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deposition and pharmacokinetics of budesonide from the Miat Monodose inhaler, a simple dry powder device.
    Ball DJ; Hirst PH; Newman SP; Sonet B; Streel B; Vanderbist F
    Int J Pharm; 2002 Oct; 245(1-2):123-32. PubMed ID: 12270249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.